Public Health in 2024: Historic Firsts, Unwelcome Comebacks, and Rays of Hope
As we head into 2025—a year certain to bring great change—we reflect on 2024’s public health headlines.
Financing, supply, policy, advocacy, and communication to improve health and survival with life saving vaccines worldwide
Explore the latest public health research and insights about vaccines.
As we head into 2025—a year certain to bring great change—we reflect on 2024’s public health headlines.
Looking for prominent public health experts in the field of vaccines? They’re here at the Bloomberg School of Public Health.
Anna Durbin, MD, studies experimental vaccines for SARS-CoV-2, dengue, West Nile, Zika, malaria, and more in human clinical trials and in controlled human infection studies.
Daniel Salmon, PhD ’03, MPH, is a vaccinologist who conducts epidemiological and behavioral studies to assess the safety of vaccines and improve vaccine decision-making.